Your session is about to expire
← Back to Search
Neuromodulation
Neuromodulation for Chronic Pain
N/A
Recruiting
Research Sponsored by Alberta Health Services, Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Summary
This trial is testing whether electrical brain stimulation can help relieve chronic pain and other disorders.
Who is the study for?
This trial is for individuals who experience chronic pain and are candidates for a neuromodulation device implant, which they have agreed to receive. Participants must be able to communicate in English.
What is being tested?
The study aims to test the effectiveness of different stimulation settings on a neuromodulation device that's implanted in patients with chronic pain conditions.
What are the potential side effects?
While specific side effects aren't listed, typical risks may include discomfort at the implant site, potential infection, or changes in sensation due to varying stimulation parameters.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in baseline pain measures
Secondary study objectives
Effect of stimulation on quality of life
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Industry standard stimulationActive Control1 Intervention
Industry standard stimulation settings
Group II: Experimental stimulationPlacebo Group1 Intervention
Experimental stimulation settings
Find a Location
Who is running the clinical trial?
Alberta Health Services, CalgaryLead Sponsor
13 Previous Clinical Trials
2,544 Total Patients Enrolled
1 Trials studying Chronic Pain
91 Patients Enrolled for Chronic Pain
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are planning to have a neuromodulation device implanted and have already agreed to it.
Research Study Groups:
This trial has the following groups:- Group 1: Industry standard stimulation
- Group 2: Experimental stimulation
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Chronic Pain Patient Testimony for trial: Trial Name: NCT04933370 — N/A
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger